Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid sus...